Endoscopic Palliation of Pancreatic Cancer

Gastroenterology Clinics of North America

Volumn 41, Issue 1, 2012, Pages 237-253

  Lo, Simon K ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biliary decompression; Celiac plexus neurolysis; Fiducial placement; Intestinal stenting; Palliation; Pancreatic adenocarcinoma

Indexed keywords

ADENOVIRUS VECTOR; NARCOTIC ANALGESIC AGENT; REPLICATION DEFECTIVE ADENOVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; BACKACHE; BILE DUCT BYPASS; BILE DUCT OBSTRUCTION; BILE DUCT STENTING; BILIARY DECOMPRESSION; BILIARY TRACT SURGERY; BRACHYTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PAIN; CANCER PALLIATIVE THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG ELUTING STENT; DRUG HYPERSENSITIVITY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC THERAPY; FIDUCIAL MARKER; GASTRODUODENAL OBSTRUCTION; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE COST; HEMOSTASIS; HEPATOJEJUNOSTOMY; HUMAN; INTESTINE OBSTRUCTION; INTESTINE STENTING; INTESTINE SURGERY; MEDICAL DECISION MAKING; METAL STENT; NERVE BLOCK; NEUROLYSIS; OBSTRUCTIVE JAUNDICE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS STENT; PLASTIC STENT; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPHINCTEROTOMY; STENT; STEREOTACTIC RADIOSURGERY; SURGICAL TECHNIQUE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ADENOCARCINOMA; ENDOSCOPY, DIGESTIVE SYSTEM; HUMANS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; STENTS;

EID: 84857077495     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.12.005     Document Type: Review

References (85)

1. SEER Cancer Statistics Review 1975-2006 National Cancer Institute, Bethesda (MD): National Cancer Institute, Accessed January 9, 2012. http://seer.cancer.gov/csr/1975_2006.
2. Merrill R.M., Hunter B.D. Conditional survival among cancer patients in the United States. Oncologist 2010, 15:873-882.
3. Saif M.W. Pancreatic neoplasm in 2011: an update. JOP 2011, 12(4):316-321.
4. Seynaeve L., Van Steenbergen W. Treatment, by insertion of multiple uncovered metallic stents, of intraductal papillary mucinous neoplasm of the pancreas with biliary obstruction by mucus impaction. Pancreatology 2007, 7:540-543.
5. Cipolletta L., Rotondano G., Marmo R., et al. Endoscopic palliation of malignant obstructive jaundice: an evidence-based review. Dig Liver Dis 2007, 39:375-388.
6. Shepherd H.A., Royle G., Ross A.P., et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988, 75:1166-1168.
7. Andersen J.R., Sorensen S.M., Kruse A., et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989, 30:1132-1135.
8. Smith A.C., Dowsett J.F., Russell R.C., et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994, 344:1655-1660.
9. Binmoeller K.F., Seitz U., Seifert H., et al. The Tannenbaum stent: a new plastic biliary stent without side holes. Am J Gastroenterol 1995, 90:1764-1768.
10. Catalano M.F., Geenen J.E., Lehman G.A., et al. "Tannenbaum" Teflon stents versus traditional polyethylene stents for treatment of malignant biliary stricture. Gastrointest Endosc 2002, 55:354-358.
11. Huibregtse K., Cheng J., Coene P.P., et al. Endoscopic placement of expandable metal stents for biliary strictures-a preliminary report on experience with 33 patients. Endoscopy 1989, 21:280-282.
12. Davids P.H., Groen A.K., Rauws E.A., et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992, 340:1488-1492.
13. Knyrim K., Wagner H.J., Pausch J., et al. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 1993, 25:207-212.
14. Moss A.C., Morris E., Leyden J., et al. Do the benefits of metal stents justify the costs?. A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol 2007, 19(12):1119-1124.
15. Yoon W.J., Ryu J.K., Yang K.Y., et al. A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost. Gastrointest Endosc 2009, 70:284-289.
16. Han Y.M., Jin G.Y., Lee S.O., et al. Flared polyurethane-covered self-expandable nitinol stent for malignant biliary obstruction. J Vasc Interv Radiol 2003, 14:1291-1301.
17. Willingham F.F. All wrapped up: metal biliary stents and the effects of stent coverings. Gastrointest Endosc 2010, 72:924-926.
18. Siddiqui A.A., Mehendiratta V., Loren D., et al. Fully covered self-expandable metal stents are effective and safe to treat distal malignant biliary strictures, irrespective of surgical resectability status. J Clin Gastroenterol 2011, 45:824-827.
19. Yoon J.W., Lee J.K., Lee K.H., et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc 2006, 63:996-1000.
20. Telford J.J., Carr-Locke D.L., Baron T.H., et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc 2010, 72:907-914.
21. Kullman E., Frozanpor F., Söderlund C., et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized multicenter study. Gastrointest Endosc 2010, 72:915-923.
22. Kim Y.S., Gupta K., Mallery S., et al. Endoscopic ultrasound rendezvous for bile duct access using a transduodenal approach: cumulative experience at a single center. A case series. Endoscopy 2010, 42:496-502.
23. Maranki J., Hernandez A.J., Arslan B., et al. Interventional endoscopic ultrasound-guided cholangiography: long-term experience of an emerging alternative to percutaneous transhepatic cholangiography. Endoscopy 2009, 41:532-538.
24. Hara K., Yamao K., Mizuno N., et al. Endoscopic ultrasound-guided choledochoduodenostomy. Dig Endosc 2010, 22:147-150.
25. Yamao K., Bhatia V., Mizuno N., et al. EUS-guided choledochoduodenostomy for palliative biliary drainage in patients with malignant biliary obstruction: results of long-term follow-up. Endoscopy 2008, 40:340-342.
26. Kahaleh M., Hernandez A.J., Tokar J., et al. Interventional EUS-guided cholangiography: evaluation of a technique in evolution. Gastrointest Endosc 2006, 64:52-59.
27. Bories E., Pesenti C., Caillol F., et al. Transgastric endoscopic ultrasonography-guided biliary drainage: results of a pilot study. Endoscopy 2007, 39:287-291.
28. Park do H., Koo J.E., Oh J., et al. EUS-guided biliary drainage with one-step placement of a fully covered metal stent for malignant biliary obstruction: a prospective feasibility study. Am J Gastroenterol 2009, 104:2168-2174.
29. Suk K.T., Kim J.W., Kim H.S., et al. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study. Gastrointest Endosc 2007, 66:798-803.
30. Lillemoe K.D., Cameron J.L., Hardacre J.M., et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer?. A prospective randomized trial. Ann Surg 1999, 230:322-328.
31. Telford J.J., Carr-Locke D.L., Baron T.H., et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 2004, 60:916-920.
32. Wong Y.T., Brams D.M., Munson L., et al. Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation. Surg Endosc 2002, 16(2):310-312.
33. Maetani I., Tada T., Ukita T., et al. Comparison of duodenal stent placement with surgical gastrojejunostomy for palliation in patients with duodenal obstructions caused by pancreaticobiliary malignancies. Endoscopy 2004, 36:73-78.
34. Mehta S., Hindmarsh A., Cheong E., et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc 2006, 20:239-242.
35. Kruse E.J. Palliation in pancreatic cancer. Surg Clin North Am 2010, 90:355-364.
36. Maire F., Hammel P., Ponsot P., et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable denocarcinoma of the head of pancreas. Am J Gastroenterol 2006, 101:735-742.
37. Pannala R., Brandabur J.J., Gan S.I. Afferent limb syndrome and delayed GI problems after pancreaticoduodenectomy for pancreatic cancer: single-center, 14-year experience. Gastrointest Endosc 2011, 74:295-302.
38. Akaraviputh T., Trakarnsanga A., Tolan K. Endoscopic treatment of acute ascending cholangitis in a patient with Roux-en-Y limb obstruction after a Whipple operation. Endoscopy 2010, 42(Suppl 2):E335-E336.
39. Harrison M.A., Hamilton S.W. Palliation of pancreatic cancer pain by endoscopic stent placement. Gastrointest Endosc 1989, 35:443-445.
40. Costamagna G., Mutignani M. Pancreatic stenting for malignant ductal obstruction. Dig Liver Dis 2004, 36:635-638.
41. Tham T.C., Lichtenstein D.R., Vandervoort J., et al. Pancreatic duct stents for "obstructive type" pain in pancreatic malignancy. Am J Gastroenterol 2000, 95:956-960.
42. Keeley S.P., Freeman M.L. Placement of self-expanding metallic stents in the pancreatic duct for treatment of obstructive complications of pancreatic cancer. Gastrointest Endosc 2003, 57:756-759.
43. Rykowski J.J., Hilgier M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Anesthesiology 2000, 92(2):347-354.
44. Gress F., Schmitt C., Sherman S., et al. A prospective randomized comparison of endoscopic ultrasound- and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol 1999, 94:900-905.
45. Yan B.M., Myers R.P. Neurolytic celiac plexus block for pain control in unresectable pancreatic cancer. Am J Gastroenterol 2007, 102:430-438.
46. Johnson C.D., Berry D.P., Harris S., et al. An open randomized comparison of clinical effectiveness of protocol-driven opioid analgesia, celiac plexus block or thoracoscopic splanchnicectomy for pain management in patients with pancreatic and other abdominal malignancies. Pancreatology 2009, 9:755-756.
47. Chak A. What is the evidence for EUS-guided celiac plexus block/neurolysis?. Gastrointest Endosc 2009, 69:S172-S173.
48. Puli S.R., Reddy J.B., Bechtold M.L., et al. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci 2009, 54:2330-2337.
49. Leblanc J.K., Al-Haddad M., McHenry L., et al. A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two?. Gastrointest Endosc 2011, 74(6):1300-1307.
50. Penman I.D., et al. Basic technique for celiac plexus block/neurolysis. Gastrointest Endosc 2009, 69:S163-S165.
51. Ascunce G., Ribeiro A., Reis I., et al. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy (with video). Gastrointest Endosc 2011, 73:267-274.
52. Sakamoto H., Kitano M., Kamata K., et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle. Am J Gastroenterol 2010, 105:2599-2606.
53. Virtue M.A., Levy M.J. Editorial: Neurolysis for pancreatic cancer pain: same song, different verse?. Am J Gastroenterol 2010, 105:2607-2609.
54. Tsirlis T., Vasiliades G., Koliopanos A., et al. Pancreatic leak related hemorrhage following pancreaticoduodenectomy. A case series. JOP 2009, 10:492-495.
55. Standop J., Schäfer N., Overhaus M., et al. Endoscopic management of anastomotic hemorrhage from pancreatogastrostomy. Surg Endosc 2009, 23:2005-2010.
56. Lillemoe K.D., Kaushal S., Cameron J.L., et al. Distal pancreatectomy: indication and outcome in 235 patients. Ann Surg 1999, 229:693-700.
57. Rieder B., Krampulz D., Adolf J., et al. Endoscopic pancreatic sphincterotomy and stenting for preoperative prophylaxis of pancreatic fistula after distal pancreatectomy. Gastrointest Endosc 2010, 72:536-542.
58. Goasguen N., Bourrier A., Ponsot P., et al. Endoscopic management of pancreatic fistula after distal pancreatectomy and enucleation. Am J Surg 2009, 197(6):715-720.
59. Sun S., Qingjie L., Qiyong G., et al. EUS-guided interstitial brachytherapy of the pancreas: a feasibility study. Gastrointest Endosc 2005, 62:775-779.
60. Sun S., Xu H., Xin J., et al. Endoscopic ultrasound-guided interstitial brachytherapy of unresectable pancreatic cancer: results of a pilot trial. Endoscopy 2006, 38:399-403.
61. Jin Z., Du Y., Li Z., et al. EUS-guided interstitial implantation of iodine 125 seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy 2008, 40:314-320.
62. Du Y.Q., Li Z.S., Jin Z.D. Endoscope-assisted brachytherapy for pancreatic cancer: from tumor killing to pain relief and drainage. J Interv Gastroenterol 2011, 1:23-27.
63. Chadha M.K., Litwin A., Levea C., et al. Surgical resection after TNFerade therapy for locally advanced pancreatic cancer. JOP 2009, 10(5):535-538.
64. Mutignani M., Shah S.K., Morganti A.G., et al. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung. Endoscopy 2002, 34:555-559.
65. Liu Y., Liu J.L., Cai Z.Z., et al. A novel approach for treatment of unresectable extrahepatic bile duct carcinoma: design of radioactive stents and an experimental trial in healthy pigs. Gastrointest Endosc 2009, 69:517-524.
66. Pishvaian A.C., Collins B., Gagnon G., et al. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointest Endosc 2006, 64(3):412-417.
67. Ammar T., Coté G.A., Creach K.M., et al. Fiducial placement for stereotactic radiation by using EUS: feasibility when using a marker compatible with a standard 22-gauge needle. Gastrointest Endosc 2010, 71:630-633.
68. DiMaio C.J., Nagula S., Goodman K.A., et al. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle (with videos). Gastrointest Endosc 2010, 71:1204-1210.
69. Faylona J.M., Qadir A., Chan A.C., et al. Small-bowel perforations related to endoscopic retrograde cholangiopancreatography (ERCP) in patients with Billroth II gastrectomy. Endoscopy 1999, 31:546-549.
70. Kim M.H., Lee S.K., Lee M.H., et al. Endoscopic retrograde cholangiopancreatography and needle knife sphincterotomy in patients with Billroth II gastrectomy: a comparative study of the forward-viewing endoscope and the side-viewing duodenoscope. Endoscopy 1997, 29:82-85.
71. Andriulli A., Loperfido S., Napolitano G., et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007, 102:1781-1788.
72. Kaassis M., Boyer J., Dumas R., et al. Plastic or metal stents for malignant stricture of the common bile duct?. Results of a randomized prospective study. Gastrointest Endosc 2003, 57:178-182.
73. Prat F., Chapat O., Ducot B., et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc 1998, 47:1-7.
74. Kahaleh M., Tokar J., Conaway M.R., et al. Efficacy and complications of covered Wallstents in malignant distal biliary obstruction. Gastrointest Endosc 2005, 61:528-533.
75. Garcia Figueiras R., Otero Echart M., Garcia Gonzalez R., et al. Colocutaneous fistula relating to the migration of a biliary stent. Eur J Gastroenterol Hepatol 2001, 13:1251-1253.
76. Lee T.H., Park D.H., Park J.Y., et al. Aortoduodenal fistula and aortic aneurysm secondary to biliary stent-induced retroperitoneal perforation. World J Gastroenterol 2008, 14:3095-3097.
77. Ikeda T., Nagata S., Ohgaki K. Intestinal obstruction because of a migrated metallic biliary stent. Gastrointest Endosc 2004, 60:988-989.
78. Hara K., Yamao K., Mizuno N., et al. Interventional endoscopic ultrasonography for pancreatic cancer. World J Clin Oncol 2011, 2(2):108-114.
79. Baron T.H., Harewood G.C. Enteral self-expandable stents. Gastrointest Endosc 2003, 58:421-433.
80. Muscatiello N., Panella C., Pietrini L., et al. Complication of endoscopic ultrasound-guided celiac plexus neurolysis. Endoscopy 2006, 38(8):858.
81. Eisenberg E., Carr D.B., Chalmers T.C. Neurolytic celiac plexus block for treatment of cancer pain: A meta-analysis. Anesth Analg 1995, 80:290-295.
82. Gunaratnam N.T., Sarma A.V., Norton I.D., et al. A prospective study of EUS guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc 2001, 54:316-324.
83. Price L.H. Good stents gone bad: endoscopic treatment of proximally migrated pancreatic duct stents. Gastrointest Endosc 2009, 70(1):174-179.
84. Sanders M.K., Moser A.J., Khddalid A., et al. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest Endosc 2010, 71:1178-1184.
85. Park W.G., Yan B.M., Schellenberg D., et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc 2010, 71:513-518.